FORMULATION AND EVALUATION OF INSITU GEL: AN OVERVIEW

• Author Information

  Jenie Watts, Parvinder Kaur, Chandan Sharma

• Jenie Watts, Parvinder Kaur, Chandan Sharma
• FORMULATION AND EVALUATION OF INSITU GEL: AN OVERVIEW

Abstract

The body's most sensitive organ is the eye. The complex functional construction of the eye, minor absorbent surface, low-slung transparency of cornea, the lipophilicity of epithelium of cornea, pre-corneal damage (due to drainage of nasolacrimal), drug attachment with proteins in tear liquid, blinking, and low conjunctival sac volume make designing an ocular drug distribution scheme the most difficult task for pharmaceutical researchers. Fewer than 5% of administered drugs enter eye. There is a lot of kinds of stuff being completed on novel drug conveyance systems for ocular management to upsurge the bioavailability of ophthalmic drugs. The efficiency of medication administration is augmented by altering the release profile, and these innovative drug delivery methods also lessen drug toxicity, giving them a number of advantages over conventional systems. There is various research being done in this field that supports the idea that in situ crystallizing systems can be useful for the administration of ocular medications. Medication distribution systems known as in situ gel schemes mainly experience in situ gelation to produce a gel after administration in the body. This process is initiated by an external stimulus like temperature, pH, or other factors. This study will give a brief overview of in situ gels, distinct in situ crystallizing system practices, the many kinds of polymers utilized in situ gels, its gel formation mechanisms, then the assessment of polymeric in situ gels. Keywords: Ocular Gel, In situ gel, Carbopol, Gellan gum, Polymers, etc.